High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells

por Blystad, AK, Holte, H, Kvaløy, S, Smeland, E, Delabie, J, Kvalheim, G
Publicado 2001

Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma

por Stokke, T, DeAngelis, P, Smedshammer, L, Galteland, E, Steen, H B, Smeland, E B, Delabie, J, Holte, H
Publicado 2001

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma

por Leivonen, S-K, Taskinen, M, Cervera, A, Karjalainen-Lindsberg, M-L, Delabie, J, Holte, H, Lehtonen, R, Hautaniemi, S, Leppä, S
Publicado 2017